Lung Cancer 2000, 30:73–81.PubMedCrossRef 4. Wolff H, Saukkonen

K, Anttila S, Karjalainen A, Vainio H, Ristimäki A: Expression of cyclooxygenase-2 in human Torin 1 datasheet lung carcinoma. Cancer Res 1998, 58:4997–5001.PubMed 5. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in MEK162 molecular weight adenocarcinomas. Cancer Res 1998, 58:3761–4.PubMed 6. Diperna CA, Bart RD, Sievers EM, Ma Y, Starnes VA, Bremner RM: Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma. J Thorac VS-4718 purchase Cardiovasc Surg 2003,126(4):1129–33.PubMedCrossRef 7. Grimminger PP, Stöhlmacher J, Vallböhmer D, Schneider PM, Hölscher AH, Metzger R, Danenberg PV, Brabender J: Prognostic significance and clinicopathological associations of COX-2 SNP in patients with nonsmall cell

lung cancer. J Oncol 2009, 139590. Epub 2009 Nov 22 8. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT: COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000,89(12):2637–45.PubMedCrossRef 9. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Research 1998,58(22):4997–5001.PubMed 10. Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M: Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues, and nonsmall

cell lung cancers. Jpn J Cancer Res 1999, 90:1338–43.PubMed 11. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997, 94:3336–40.PubMedCrossRef 12. Nie D, Honn KV: Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci 2002, 59:799–807.PubMedCrossRef 13. Nie D, Lamberti M, Zacharek A, Li L, Szekeres K, Tang K, Chen Y, Honn KV: Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 2000, 267:245–51.PubMedCrossRef 14. ID-8 Sobin LH, Wittekind C: International Union Against Cancer (UICC) TNM classification of malignant tumors. 6th edition. New York, NY: Wiley-Liss; 2002:99–103. 15. Travis WD, Brambilla E, Muller-Hermelink HK: WHO classification of tumors. Pathology and Genetics. Tumors of lung, pleura, thymus and heart. IARC Press, Lyon; 2004:9–124. 16. Samuelsson B, Morgenstern R, Jakobsson PJ: Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007,59(3):207–24.PubMedCrossRef 17. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987, 235:442–7.PubMedCrossRef 18. Gupta MK, Qin RY: Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 2003,9(6):1144–55.PubMed 19.